Welcome to our dedicated page for COGNEX SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Cognex Corp director Dianne M. Parrotte increased her direct ownership through an equity award event. On February 21, 2026, she exercised or converted 2,913 Restricted Stock Units into 2,913 shares of Cognex common stock at a stated price of $0.0000 per share, indicating no cash outlay in this transaction. Following the conversion, her directly held common stock position rose to 33,431 shares. The filing also reports outstanding Non-Qualified Stock Options with direct ownership covering 7,500, 18,400, and 18,100 shares, which remain as rights to buy stock.
Cognex Corp director Angelos Papadimitriou reported a mix of stock transactions. On February 23, 2026, he sold 4,150 shares of common stock in an open-market transaction at an average price of $55.5804 per share, leaving 16,222 common shares directly owned.
On February 21, 2026, restricted stock units covering 2,537 shares were exercised and converted into the same number of common shares at no cash exercise price, increasing his common stock before the sale to 20,372 shares. Following these transactions, he also directly holds 4,817 restricted stock units that vest over time under a prior grant.
COGNEX CORP director John Tseng-Chung Lee exercised restricted stock units into common shares. He converted 2,913 restricted stock units into 2,913 shares of common stock at a stated price of $0.00 per share. After these transactions, he directly holds 24,820 common shares and 4,817 restricted stock units, which will vest over time based on the original grant schedule.
Cognex Corporation director Marjorie Sennett reported the exercise and conversion of 2,913 restricted stock units into an equal number of Cognex common shares at a price of $0.00 per share. After this transaction, she directly holds 25,936 common shares and 4,817 restricted stock units.
The restricted stock units each represent a contingent right to receive one share of common stock and vest in stages of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.
COGNEX CORP director Sachin Lawande exercised restricted stock units into common shares. On February 21, 2026, he converted 2,913 restricted stock units into 2,913 shares of Cognex common stock at $0.00 per share through a derivative exercise.
After this transaction, he directly held 28,431 shares of common stock and 4,817 restricted stock units. Each restricted stock unit represents a right to receive one share of Cognex common stock, and these units vest 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.
Cognex director Anthony Sun reported an equity award transaction involving restricted stock units (RSUs) and common shares. On February 21, 2026, he exercised 2,913 RSUs, converting them at $0.00 per unit into 2,913 shares of Cognex common stock held directly. Following this conversion, his directly held common stock position reported in this filing is 335,085 shares, while the exercised RSU grant balance is now 0 units.
The filing also lists additional indirect holdings through Sun Management Associates, LLC, including several non-qualified stock options with reported remaining amounts ranging from 13,000 to 26,000 shares and 52,608 shares of common stock. A footnote states that Sun is a member of this LLC and disclaims beneficial ownership of those securities except to the extent of his pecuniary interest. Another footnote explains that each RSU represents a contingent right to receive one share of Cognex common stock and that the applicable RSU award vests 20%, 30%, and 50% on the first, second, and third anniversaries of its February 21, 2023 grant date.
Cognex Corporation CEO & President Matthew Moschner reported equity compensation activity involving restricted stock units and related tax withholding. On February 20 and 21, 2026, restricted stock units covering 3,042 and 3,495 shares were exercised into an equal number of Cognex common shares at $0.00 per share.
To satisfy tax withholding obligations on these vesting awards, 893 and 1,026 common shares were automatically withheld at a price of $56.03 per share, as described in the footnotes. After these transactions, Moschner held 16,465 shares of Cognex common stock directly, along with multiple outstanding non-qualified stock options and additional restricted stock units.
COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales. On February 20–21, 2026, he exercised multiple non-qualified stock options and restricted stock units, receiving Cognex common stock through derivative exercises at stated exercise prices such as $33.04, $38.39, and $39.44 per share.
He then sold a total of 61,900 shares of common stock in open-market transactions at prices around $55.98–$56.24, and some additional shares were disposed of to satisfy tax withholding obligations on vested restricted stock units, as described in the footnotes. After these transactions, Kuechen directly owned 6,032 shares of Cognex common stock.
Cognex EVP Carl Gerst reported a series of stock transactions involving Cognex common shares and restricted stock units. On February 20, 2026, he exercised restricted stock units into 6,846 common shares and another 6,846 common shares, then had 2,010 shares withheld to cover tax obligations and sold 3,804 shares in open‑market trades at about $55.99 per share. On February 21, 2026, additional restricted stock units converted into 8,791 common shares, with 3,095 shares withheld for taxes. On February 23, 2026, he sold 10,532 common shares in open‑market transactions at an average price of about $55.93 per share under a Rule 10b5‑1 trading plan. After these trades, his reported direct common‑stock holdings were 0 shares, while the filing notes outstanding restricted stock units that vest 20%, 30%, and 50% on the first, second, and third anniversaries of the 2023 and 2024 grant dates.